Transmucosal delivery system for medicinal active ingredient to submucosa of bladder
WO2020171212A1
Method for improving storage stability
WO2020101013A1
Pharmaceutical composition
WO2020067507A1
Primary amine compound- or secondary amine compound-acidic polysaccharide conjugate, and method for producing same
WO2020071229A1
Method for enhancing sensitivity of endotoxin measuring agent
WO2020050378A1
Polymer conjugate including tertiary amine compound or imine compound bonded, and production method therefor
WO2019189876A1
(carboxylic acid-type compound)-polymer conjugate having biological activity, and method for producing same
CN111902149A
Promoter for hyaluronic acid synthesis, method for promoting hyaluronic acid synthesis, and cell evaluation method
KR20200126993A
Pharmaceutical composition, package and manufacturing method thereof
CN111801114A
Package and method for manufacturing same
US2019184023A1
Glycosaminoglycan derivative and method for producing same
EP3695823A1
Drug storage container, closing member, method for manufacture of drug storage container, method for inspection of microorganisms and contaminants, and solid preparation for buffer solution preparation
US2020138964A1
Tertiary amine compound or imine compound-polymer conjugate and production method therefor
BR112019018172A2
composition to treat a human joint disease, and, kit.
WO2018168920A1
Composition for treating joint diseases and kit including same
SG11201907866SA
Horseshoe crab factor b variant
WO2018074498A1
Recombinant proteins derived from genus limulus, and dna molecules encoding same
WO2017141961A1
Electrochemical measurement using phenylenediamine derivative
EP3409292A1
Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid
